nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—CA5B—coronary artery disease	0.303	0.641	CbGaD
Dobutamine—ADRB1—coronary artery disease	0.0923	0.195	CbGaD
Dobutamine—ADRB2—coronary artery disease	0.0776	0.164	CbGaD
Dobutamine—CA5A—Furosemide—coronary artery disease	0.0695	0.195	CbGbCtD
Dobutamine—CA5B—Furosemide—coronary artery disease	0.0606	0.17	CbGbCtD
Dobutamine—ADRB2—Penbutolol—coronary artery disease	0.0543	0.153	CbGbCtD
Dobutamine—ADRB1—Penbutolol—coronary artery disease	0.0535	0.15	CbGbCtD
Dobutamine—CA2—Furosemide—coronary artery disease	0.042	0.118	CbGbCtD
Dobutamine—ADRB2—Timolol—coronary artery disease	0.0383	0.108	CbGbCtD
Dobutamine—ADRB1—Timolol—coronary artery disease	0.0377	0.106	CbGbCtD
Dobutamine—CA5B—cervicothoracic ganglion—coronary artery disease	0.0196	0.442	CbGeAlD
Dobutamine—CA5B—sinoatrial node—coronary artery disease	0.0126	0.285	CbGeAlD
Dobutamine—Ventricular extrasystoles—Fenofibrate—coronary artery disease	0.00105	0.0171	CcSEcCtD
Dobutamine—COMT—cardiac ventricle—coronary artery disease	0.00103	0.0233	CbGeAlD
Dobutamine—ADRB1—cardiac ventricle—coronary artery disease	0.000874	0.0197	CbGeAlD
Dobutamine—Ventricular extrasystoles—Enalapril—coronary artery disease	0.00084	0.0137	CcSEcCtD
Dobutamine—ADRB1—myocardium—coronary artery disease	0.000822	0.0186	CbGeAlD
Dobutamine—Phlebitis—Fenofibrate—coronary artery disease	0.0008	0.013	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Perindopril—coronary artery disease	0.000782	0.0127	CcSEcCtD
Dobutamine—Skin exfoliation—Niacin—coronary artery disease	0.000761	0.0124	CcSEcCtD
Dobutamine—CA5B—heart—coronary artery disease	0.000736	0.0166	CbGeAlD
Dobutamine—Thrombocytopenia—Tirofiban—coronary artery disease	0.000719	0.0117	CcSEcCtD
Dobutamine—Hypokalaemia—Acetylsalicylic acid—coronary artery disease	0.000703	0.0114	CcSEcCtD
Dobutamine—CA5B—cardiovascular system—coronary artery disease	0.000694	0.0157	CbGeAlD
Dobutamine—COMT—heart—coronary artery disease	0.000678	0.0153	CbGeAlD
Dobutamine—CA2—cardiac ventricle—coronary artery disease	0.000641	0.0145	CbGeAlD
Dobutamine—COMT—cardiovascular system—coronary artery disease	0.000639	0.0144	CbGeAlD
Dobutamine—Skin exfoliation—Losartan—coronary artery disease	0.000633	0.0103	CcSEcCtD
Dobutamine—CA5B—cardiac atrium—coronary artery disease	0.000629	0.0142	CbGeAlD
Dobutamine—CA2—myocardium—coronary artery disease	0.000603	0.0136	CbGeAlD
Dobutamine—Hypokalaemia—Eplerenone—coronary artery disease	0.000588	0.00957	CcSEcCtD
Dobutamine—Angina pectoris—Fenofibrate—coronary artery disease	0.000581	0.00945	CcSEcCtD
Dobutamine—COMT—cardiac atrium—coronary artery disease	0.00058	0.0131	CbGeAlD
Dobutamine—ADRB1—heart—coronary artery disease	0.000574	0.013	CbGeAlD
Dobutamine—Angina pectoris—Clopidogrel—coronary artery disease	0.000571	0.00929	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Lisinopril—coronary artery disease	0.000571	0.00928	CcSEcCtD
Dobutamine—CA5B—blood—coronary artery disease	0.000549	0.0124	CbGeAlD
Dobutamine—Angina pectoris—Eplerenone—coronary artery disease	0.000544	0.00885	CcSEcCtD
Dobutamine—ADRB1—cardiovascular system—coronary artery disease	0.000542	0.0122	CbGeAlD
Dobutamine—Hypokalaemia—Olmesartan—coronary artery disease	0.000539	0.00876	CcSEcCtD
Dobutamine—COMT—blood—coronary artery disease	0.000506	0.0114	CbGeAlD
Dobutamine—Angina pectoris—Olmesartan—coronary artery disease	0.000498	0.00811	CcSEcCtD
Dobutamine—Hypokalaemia—Telmisartan—coronary artery disease	0.000494	0.00804	CcSEcCtD
Dobutamine—ADRB1—cardiac atrium—coronary artery disease	0.000491	0.0111	CbGeAlD
Dobutamine—Angina pectoris—Niacin—coronary artery disease	0.000487	0.00792	CcSEcCtD
Dobutamine—Angina pectoris—Pravastatin—coronary artery disease	0.000479	0.0078	CcSEcCtD
Dobutamine—Angina pectoris—Trandolapril—coronary artery disease	0.000466	0.00757	CcSEcCtD
Dobutamine—Dyspnoea—Penbutolol—coronary artery disease	0.000464	0.00755	CcSEcCtD
Dobutamine—Angina pectoris—Enalapril—coronary artery disease	0.000464	0.00754	CcSEcCtD
Dobutamine—Chest pain—Gemfibrozil—coronary artery disease	0.000463	0.00754	CcSEcCtD
Dobutamine—Headache—Tirofiban—coronary artery disease	0.00046	0.00748	CcSEcCtD
Dobutamine—Angina pectoris—Telmisartan—coronary artery disease	0.000457	0.00744	CcSEcCtD
Dobutamine—Hypokalaemia—Furosemide—coronary artery disease	0.000454	0.00738	CcSEcCtD
Dobutamine—Chest pain—Ticagrelor—coronary artery disease	0.000453	0.00736	CcSEcCtD
Dobutamine—Angina pectoris—Captopril—coronary artery disease	0.000445	0.00724	CcSEcCtD
Dobutamine—Pruritus—Pitavastatin—coronary artery disease	0.000444	0.00722	CcSEcCtD
Dobutamine—Nausea—Tirofiban—coronary artery disease	0.000436	0.0071	CcSEcCtD
Dobutamine—Thrombocytopenia—Gemfibrozil—coronary artery disease	0.000435	0.00707	CcSEcCtD
Dobutamine—Angina pectoris—Perindopril—coronary artery disease	0.000432	0.00702	CcSEcCtD
Dobutamine—CA2—heart—coronary artery disease	0.000421	0.00951	CbGeAlD
Dobutamine—Hypotension—Ticagrelor—coronary artery disease	0.000405	0.0066	CcSEcCtD
Dobutamine—Angina pectoris—Losartan—coronary artery disease	0.000405	0.00659	CcSEcCtD
Dobutamine—CA2—cardiovascular system—coronary artery disease	0.000397	0.00897	CbGeAlD
Dobutamine—Chest pain—Acetylsalicylic acid—coronary artery disease	0.000396	0.00644	CcSEcCtD
Dobutamine—Headache—Pitavastatin—coronary artery disease	0.000393	0.00639	CcSEcCtD
Dobutamine—Dyspnoea—Ticagrelor—coronary artery disease	0.000387	0.00629	CcSEcCtD
Dobutamine—Thrombocytopenia—Rosuvastatin—coronary artery disease	0.000382	0.00622	CcSEcCtD
Dobutamine—Nausea—Pitavastatin—coronary artery disease	0.000372	0.00606	CcSEcCtD
Dobutamine—Thrombocytopenia—Acetylsalicylic acid—coronary artery disease	0.000371	0.00604	CcSEcCtD
Dobutamine—Tachycardia—Acetylsalicylic acid—coronary artery disease	0.00037	0.00602	CcSEcCtD
Dobutamine—Palpitations—Fenofibrate—coronary artery disease	0.000367	0.00597	CcSEcCtD
Dobutamine—Palpitations—Clopidogrel—coronary artery disease	0.000361	0.00587	CcSEcCtD
Dobutamine—CA2—cardiac atrium—coronary artery disease	0.00036	0.00813	CbGeAlD
Dobutamine—Chest pain—Fenofibrate—coronary artery disease	0.000354	0.00575	CcSEcCtD
Dobutamine—Palpitations—Ezetimibe—coronary artery disease	0.000351	0.00572	CcSEcCtD
Dobutamine—Chest pain—Clopidogrel—coronary artery disease	0.000348	0.00565	CcSEcCtD
Dobutamine—Angina pectoris—Ramipril—coronary artery disease	0.000347	0.00565	CcSEcCtD
Dobutamine—Chest pain—Lovastatin—coronary artery disease	0.000345	0.00562	CcSEcCtD
Dobutamine—Angina pectoris—Timolol—coronary artery disease	0.00034	0.00552	CcSEcCtD
Dobutamine—Chest pain—Ezetimibe—coronary artery disease	0.000339	0.00551	CcSEcCtD
Dobutamine—Dyspnoea—Acetylsalicylic acid—coronary artery disease	0.000338	0.0055	CcSEcCtD
Dobutamine—Thrombocytopenia—Fenofibrate—coronary artery disease	0.000332	0.0054	CcSEcCtD
Dobutamine—Chest pain—Eplerenone—coronary artery disease	0.000331	0.00539	CcSEcCtD
Dobutamine—Tachycardia—Fenofibrate—coronary artery disease	0.000331	0.00538	CcSEcCtD
Dobutamine—Headache—Penbutolol—coronary artery disease	0.000326	0.00531	CcSEcCtD
Dobutamine—Thrombocytopenia—Lovastatin—coronary artery disease	0.000324	0.00527	CcSEcCtD
Dobutamine—Chest pain—Simvastatin—coronary artery disease	0.000323	0.00525	CcSEcCtD
Dobutamine—Thrombocytopenia—Ezetimibe—coronary artery disease	0.000318	0.00517	CcSEcCtD
Dobutamine—Hypotension—Fenofibrate—coronary artery disease	0.000317	0.00515	CcSEcCtD
Dobutamine—Palpitations—Valsartan—coronary artery disease	0.000317	0.00515	CcSEcCtD
Dobutamine—Palpitations—Olmesartan—coronary artery disease	0.000315	0.00513	CcSEcCtD
Dobutamine—Angina pectoris—Lisinopril—coronary artery disease	0.000315	0.00512	CcSEcCtD
Dobutamine—Pruritus—Gemfibrozil—coronary artery disease	0.000314	0.00511	CcSEcCtD
Dobutamine—CA2—blood—coronary artery disease	0.000314	0.00709	CbGeAlD
Dobutamine—Hypotension—Clopidogrel—coronary artery disease	0.000311	0.00507	CcSEcCtD
Dobutamine—Nausea—Penbutolol—coronary artery disease	0.000309	0.00503	CcSEcCtD
Dobutamine—Palpitations—Niacin—coronary artery disease	0.000308	0.00501	CcSEcCtD
Dobutamine—Pruritus—Ticagrelor—coronary artery disease	0.000307	0.00499	CcSEcCtD
Dobutamine—Chest pain—Valsartan—coronary artery disease	0.000305	0.00496	CcSEcCtD
Dobutamine—Chest pain—Olmesartan—coronary artery disease	0.000303	0.00494	CcSEcCtD
Dobutamine—Thrombocytopenia—Simvastatin—coronary artery disease	0.000303	0.00493	CcSEcCtD
Dobutamine—Dyspnoea—Fenofibrate—coronary artery disease	0.000302	0.00492	CcSEcCtD
Dobutamine—Dyspnoea—Clopidogrel—coronary artery disease	0.000297	0.00483	CcSEcCtD
Dobutamine—Hypotension—Eplerenone—coronary artery disease	0.000297	0.00483	CcSEcCtD
Dobutamine—Dyspnoea—Lovastatin—coronary artery disease	0.000295	0.0048	CcSEcCtD
Dobutamine—Palpitations—Trandolapril—coronary artery disease	0.000294	0.00479	CcSEcCtD
Dobutamine—Palpitations—Enalapril—coronary artery disease	0.000293	0.00477	CcSEcCtD
Dobutamine—Chest pain—Pravastatin—coronary artery disease	0.000292	0.00475	CcSEcCtD
Dobutamine—Dyspnoea—Ezetimibe—coronary artery disease	0.000289	0.00471	CcSEcCtD
Dobutamine—Palpitations—Telmisartan—coronary artery disease	0.000289	0.0047	CcSEcCtD
Dobutamine—Thrombocytopenia—Valsartan—coronary artery disease	0.000286	0.00466	CcSEcCtD
Dobutamine—Thrombocytopenia—Olmesartan—coronary artery disease	0.000285	0.00463	CcSEcCtD
Dobutamine—Tachycardia—Olmesartan—coronary artery disease	0.000284	0.00462	CcSEcCtD
Dobutamine—Chest pain—Trandolapril—coronary artery disease	0.000284	0.00461	CcSEcCtD
Dobutamine—Dyspnoea—Eplerenone—coronary artery disease	0.000283	0.00461	CcSEcCtD
Dobutamine—Chest pain—Enalapril—coronary artery disease	0.000282	0.00459	CcSEcCtD
Dobutamine—Palpitations—Captopril—coronary artery disease	0.000281	0.00457	CcSEcCtD
Dobutamine—Chest pain—Telmisartan—coronary artery disease	0.000279	0.00453	CcSEcCtD
Dobutamine—Headache—Gemfibrozil—coronary artery disease	0.000278	0.00453	CcSEcCtD
Dobutamine—Tachycardia—Niacin—coronary artery disease	0.000277	0.00451	CcSEcCtD
Dobutamine—Pruritus—Rosuvastatin—coronary artery disease	0.000276	0.0045	CcSEcCtD
Dobutamine—Dyspnoea—Simvastatin—coronary artery disease	0.000276	0.00449	CcSEcCtD
Dobutamine—Thrombocytopenia—Pravastatin—coronary artery disease	0.000274	0.00446	CcSEcCtD
Dobutamine—Hypotension—Valsartan—coronary artery disease	0.000273	0.00444	CcSEcCtD
Dobutamine—Palpitations—Perindopril—coronary artery disease	0.000273	0.00444	CcSEcCtD
Dobutamine—Hypotension—Olmesartan—coronary artery disease	0.000272	0.00442	CcSEcCtD
Dobutamine—Headache—Ticagrelor—coronary artery disease	0.000272	0.00442	CcSEcCtD
Dobutamine—Fenoterol—ADRB1—coronary artery disease	0.000271	0.0815	CrCbGaD
Dobutamine—Chest pain—Captopril—coronary artery disease	0.000271	0.00441	CcSEcCtD
Dobutamine—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000268	0.00437	CcSEcCtD
Dobutamine—Thrombocytopenia—Trandolapril—coronary artery disease	0.000266	0.00433	CcSEcCtD
Dobutamine—Hypotension—Niacin—coronary artery disease	0.000266	0.00432	CcSEcCtD
Dobutamine—Tachycardia—Trandolapril—coronary artery disease	0.000265	0.00432	CcSEcCtD
Dobutamine—Thrombocytopenia—Enalapril—coronary artery disease	0.000265	0.00431	CcSEcCtD
Dobutamine—Tachycardia—Enalapril—coronary artery disease	0.000264	0.0043	CcSEcCtD
Dobutamine—Nausea—Gemfibrozil—coronary artery disease	0.000264	0.00429	CcSEcCtD
Dobutamine—Chest pain—Perindopril—coronary artery disease	0.000263	0.00428	CcSEcCtD
Dobutamine—Thrombocytopenia—Telmisartan—coronary artery disease	0.000261	0.00425	CcSEcCtD
Dobutamine—Dyspnoea—Valsartan—coronary artery disease	0.000261	0.00424	CcSEcCtD
Dobutamine—Tachycardia—Telmisartan—coronary artery disease	0.000261	0.00424	CcSEcCtD
Dobutamine—Nausea—Ticagrelor—coronary artery disease	0.000258	0.00419	CcSEcCtD
Dobutamine—Palpitations—Losartan—coronary artery disease	0.000256	0.00417	CcSEcCtD
Dobutamine—Thrombocytopenia—Captopril—coronary artery disease	0.000254	0.00414	CcSEcCtD
Dobutamine—Hypotension—Trandolapril—coronary artery disease	0.000254	0.00413	CcSEcCtD
Dobutamine—Arbutamine—ADRB1—coronary artery disease	0.000254	0.0762	CrCbGaD
Dobutamine—Dyspnoea—Niacin—coronary artery disease	0.000253	0.00412	CcSEcCtD
Dobutamine—Tachycardia—Captopril—coronary artery disease	0.000253	0.00412	CcSEcCtD
Dobutamine—Hypotension—Enalapril—coronary artery disease	0.000253	0.00412	CcSEcCtD
Dobutamine—Dyspnoea—Pravastatin—coronary artery disease	0.00025	0.00406	CcSEcCtD
Dobutamine—Hypotension—Telmisartan—coronary artery disease	0.000249	0.00406	CcSEcCtD
Dobutamine—Thrombocytopenia—Perindopril—coronary artery disease	0.000247	0.00402	CcSEcCtD
Dobutamine—Chest pain—Losartan—coronary artery disease	0.000247	0.00401	CcSEcCtD
Dobutamine—Arformoterol—ADRB1—coronary artery disease	0.000246	0.074	CrCbGaD
Dobutamine—Formoterol—ADRB1—coronary artery disease	0.000246	0.074	CrCbGaD
Dobutamine—Tachycardia—Perindopril—coronary artery disease	0.000246	0.004	CcSEcCtD
Dobutamine—Headache—Rosuvastatin—coronary artery disease	0.000245	0.00398	CcSEcCtD
Dobutamine—Hypotension—Captopril—coronary artery disease	0.000243	0.00395	CcSEcCtD
Dobutamine—Dyspnoea—Trandolapril—coronary artery disease	0.000242	0.00394	CcSEcCtD
Dobutamine—Dyspnoea—Enalapril—coronary artery disease	0.000241	0.00393	CcSEcCtD
Dobutamine—Thrombocytopenia—Furosemide—coronary artery disease	0.00024	0.0039	CcSEcCtD
Dobutamine—Pruritus—Fenofibrate—coronary artery disease	0.00024	0.0039	CcSEcCtD
Dobutamine—Dyspnoea—Telmisartan—coronary artery disease	0.000238	0.00387	CcSEcCtD
Dobutamine—Pruritus—Clopidogrel—coronary artery disease	0.000236	0.00383	CcSEcCtD
Dobutamine—Hypotension—Perindopril—coronary artery disease	0.000236	0.00383	CcSEcCtD
Dobutamine—Pruritus—Lovastatin—coronary artery disease	0.000234	0.00381	CcSEcCtD
Dobutamine—Nausea—Rosuvastatin—coronary artery disease	0.000232	0.00377	CcSEcCtD
Dobutamine—Thrombocytopenia—Losartan—coronary artery disease	0.000231	0.00377	CcSEcCtD
Dobutamine—Dyspnoea—Captopril—coronary artery disease	0.000231	0.00377	CcSEcCtD
Dobutamine—Tachycardia—Losartan—coronary artery disease	0.000231	0.00375	CcSEcCtD
Dobutamine—Pruritus—Ezetimibe—coronary artery disease	0.00023	0.00374	CcSEcCtD
Dobutamine—Hypotension—Furosemide—coronary artery disease	0.000229	0.00373	CcSEcCtD
Dobutamine—Ritodrine—ADRB2—coronary artery disease	0.000228	0.0685	CrCbGaD
Dobutamine—Fenoterol—ADRB2—coronary artery disease	0.000228	0.0685	CrCbGaD
Dobutamine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000225	0.00367	CcSEcCtD
Dobutamine—Pruritus—Eplerenone—coronary artery disease	0.000225	0.00366	CcSEcCtD
Dobutamine—Dyspnoea—Perindopril—coronary artery disease	0.000225	0.00366	CcSEcCtD
Dobutamine—Hypotension—Losartan—coronary artery disease	0.000221	0.00359	CcSEcCtD
Dobutamine—Palpitations—Ramipril—coronary artery disease	0.00022	0.00357	CcSEcCtD
Dobutamine—Pruritus—Simvastatin—coronary artery disease	0.000219	0.00356	CcSEcCtD
Dobutamine—Palpitations—Timolol—coronary artery disease	0.000215	0.00349	CcSEcCtD
Dobutamine—Arbutamine—ADRB2—coronary artery disease	0.000213	0.0641	CrCbGaD
Dobutamine—Headache—Fenofibrate—coronary artery disease	0.000212	0.00345	CcSEcCtD
Dobutamine—Chest pain—Ramipril—coronary artery disease	0.000211	0.00344	CcSEcCtD
Dobutamine—Dyspnoea—Losartan—coronary artery disease	0.000211	0.00343	CcSEcCtD
Dobutamine—Dopamine—SLC22A3—coronary artery disease	0.00021	0.063	CrCbGaD
Dobutamine—Headache—Clopidogrel—coronary artery disease	0.000209	0.0034	CcSEcCtD
Dobutamine—Headache—Lovastatin—coronary artery disease	0.000207	0.00337	CcSEcCtD
Dobutamine—Arformoterol—ADRB2—coronary artery disease	0.000207	0.0622	CrCbGaD
Dobutamine—Formoterol—ADRB2—coronary artery disease	0.000207	0.0622	CrCbGaD
Dobutamine—Pruritus—Valsartan—coronary artery disease	0.000207	0.00337	CcSEcCtD
Dobutamine—Chest pain—Timolol—coronary artery disease	0.000207	0.00336	CcSEcCtD
Dobutamine—Pruritus—Olmesartan—coronary artery disease	0.000206	0.00335	CcSEcCtD
Dobutamine—Headache—Ezetimibe—coronary artery disease	0.000203	0.00331	CcSEcCtD
Dobutamine—Nausea—Fenofibrate—coronary artery disease	0.000201	0.00328	CcSEcCtD
Dobutamine—Pruritus—Niacin—coronary artery disease	0.000201	0.00327	CcSEcCtD
Dobutamine—Palpitations—Lisinopril—coronary artery disease	0.000199	0.00324	CcSEcCtD
Dobutamine—Headache—Eplerenone—coronary artery disease	0.000199	0.00324	CcSEcCtD
Dobutamine—Thrombocytopenia—Ramipril—coronary artery disease	0.000199	0.00323	CcSEcCtD
Dobutamine—Pruritus—Pravastatin—coronary artery disease	0.000198	0.00322	CcSEcCtD
Dobutamine—Nausea—Clopidogrel—coronary artery disease	0.000198	0.00322	CcSEcCtD
Dobutamine—Tachycardia—Ramipril—coronary artery disease	0.000198	0.00322	CcSEcCtD
Dobutamine—Nausea—Lovastatin—coronary artery disease	0.000197	0.0032	CcSEcCtD
Dobutamine—Headache—Simvastatin—coronary artery disease	0.000194	0.00316	CcSEcCtD
Dobutamine—Nausea—Ezetimibe—coronary artery disease	0.000193	0.00314	CcSEcCtD
Dobutamine—Pruritus—Trandolapril—coronary artery disease	0.000192	0.00313	CcSEcCtD
Dobutamine—Chest pain—Lisinopril—coronary artery disease	0.000192	0.00312	CcSEcCtD
Dobutamine—Pruritus—Enalapril—coronary artery disease	0.000192	0.00312	CcSEcCtD
Dobutamine—Hypotension—Ramipril—coronary artery disease	0.000189	0.00308	CcSEcCtD
Dobutamine—Pruritus—Telmisartan—coronary artery disease	0.000189	0.00307	CcSEcCtD
Dobutamine—Nausea—Eplerenone—coronary artery disease	0.000189	0.00307	CcSEcCtD
Dobutamine—Hypotension—Timolol—coronary artery disease	0.000185	0.00301	CcSEcCtD
Dobutamine—Nausea—Simvastatin—coronary artery disease	0.000184	0.00299	CcSEcCtD
Dobutamine—Pruritus—Captopril—coronary artery disease	0.000184	0.00299	CcSEcCtD
Dobutamine—Headache—Valsartan—coronary artery disease	0.000183	0.00298	CcSEcCtD
Dobutamine—Headache—Olmesartan—coronary artery disease	0.000182	0.00297	CcSEcCtD
Dobutamine—Dyspnoea—Ramipril—coronary artery disease	0.000181	0.00294	CcSEcCtD
Dobutamine—Thrombocytopenia—Lisinopril—coronary artery disease	0.00018	0.00293	CcSEcCtD
Dobutamine—Labetalol—ADRB1—coronary artery disease	0.00018	0.0541	CrCbGaD
Dobutamine—Tachycardia—Lisinopril—coronary artery disease	0.000179	0.00292	CcSEcCtD
Dobutamine—Pruritus—Perindopril—coronary artery disease	0.000178	0.0029	CcSEcCtD
Dobutamine—Arformoterol—CYP2C19—coronary artery disease	0.000178	0.0536	CrCbGaD
Dobutamine—Formoterol—CYP2C19—coronary artery disease	0.000178	0.0536	CrCbGaD
Dobutamine—Headache—Niacin—coronary artery disease	0.000178	0.0029	CcSEcCtD
Dobutamine—Dyspnoea—Timolol—coronary artery disease	0.000177	0.00287	CcSEcCtD
Dobutamine—Headache—Pravastatin—coronary artery disease	0.000175	0.00285	CcSEcCtD
Dobutamine—Nausea—Valsartan—coronary artery disease	0.000174	0.00283	CcSEcCtD
Dobutamine—Pruritus—Furosemide—coronary artery disease	0.000173	0.00282	CcSEcCtD
Dobutamine—Nausea—Olmesartan—coronary artery disease	0.000173	0.00281	CcSEcCtD
Dobutamine—Hypotension—Lisinopril—coronary artery disease	0.000172	0.0028	CcSEcCtD
Dobutamine—Headache—Trandolapril—coronary artery disease	0.00017	0.00277	CcSEcCtD
Dobutamine—Headache—Enalapril—coronary artery disease	0.00017	0.00276	CcSEcCtD
Dobutamine—Nausea—Niacin—coronary artery disease	0.000169	0.00275	CcSEcCtD
Dobutamine—Pruritus—Losartan—coronary artery disease	0.000167	0.00272	CcSEcCtD
Dobutamine—Headache—Telmisartan—coronary artery disease	0.000167	0.00272	CcSEcCtD
Dobutamine—Nausea—Pravastatin—coronary artery disease	0.000166	0.0027	CcSEcCtD
Dobutamine—Dyspnoea—Lisinopril—coronary artery disease	0.000164	0.00267	CcSEcCtD
Dobutamine—Headache—Captopril—coronary artery disease	0.000163	0.00265	CcSEcCtD
Dobutamine—Nausea—Trandolapril—coronary artery disease	0.000161	0.00263	CcSEcCtD
Dobutamine—Nausea—Enalapril—coronary artery disease	0.000161	0.00262	CcSEcCtD
Dobutamine—Nausea—Telmisartan—coronary artery disease	0.000159	0.00258	CcSEcCtD
Dobutamine—Headache—Perindopril—coronary artery disease	0.000158	0.00257	CcSEcCtD
Dobutamine—Nausea—Captopril—coronary artery disease	0.000154	0.00251	CcSEcCtD
Dobutamine—Headache—Furosemide—coronary artery disease	0.000154	0.0025	CcSEcCtD
Dobutamine—Labetalol—ADRB2—coronary artery disease	0.000151	0.0455	CrCbGaD
Dobutamine—Nausea—Perindopril—coronary artery disease	0.00015	0.00244	CcSEcCtD
Dobutamine—Headache—Losartan—coronary artery disease	0.000148	0.00241	CcSEcCtD
Dobutamine—Nausea—Furosemide—coronary artery disease	0.000146	0.00237	CcSEcCtD
Dobutamine—Pruritus—Ramipril—coronary artery disease	0.000143	0.00233	CcSEcCtD
Dobutamine—Nausea—Losartan—coronary artery disease	0.00014	0.00228	CcSEcCtD
Dobutamine—Pruritus—Timolol—coronary artery disease	0.00014	0.00228	CcSEcCtD
Dobutamine—Dopamine—HTR7—coronary artery disease	0.000133	0.04	CrCbGaD
Dobutamine—Pruritus—Lisinopril—coronary artery disease	0.00013	0.00212	CcSEcCtD
Dobutamine—Headache—Ramipril—coronary artery disease	0.000127	0.00207	CcSEcCtD
Dobutamine—Headache—Timolol—coronary artery disease	0.000124	0.00202	CcSEcCtD
Dobutamine—Nausea—Ramipril—coronary artery disease	0.00012	0.00196	CcSEcCtD
Dobutamine—Nausea—Timolol—coronary artery disease	0.000118	0.00192	CcSEcCtD
Dobutamine—Headache—Lisinopril—coronary artery disease	0.000115	0.00187	CcSEcCtD
Dobutamine—Dopamine—ADRB1—coronary artery disease	0.000114	0.0343	CrCbGaD
Dobutamine—Nausea—Lisinopril—coronary artery disease	0.000109	0.00178	CcSEcCtD
Dobutamine—Dopamine—CYP2C19—coronary artery disease	8.25e-05	0.0248	CrCbGaD
Dobutamine—ADRB2—Signaling Pathways—CYBB—coronary artery disease	8.51e-06	0.000137	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDE4B—coronary artery disease	8.51e-06	0.000137	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CXCL8—coronary artery disease	8.51e-06	0.000137	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MMP3—coronary artery disease	8.5e-06	0.000137	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ALB—coronary artery disease	8.39e-06	0.000135	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EDN1—coronary artery disease	8.26e-06	0.000133	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCL5—coronary artery disease	8.2e-06	0.000132	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PRKCD—coronary artery disease	8.13e-06	0.000131	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EDN1—coronary artery disease	8.08e-06	0.00013	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CSF2—coronary artery disease	8.07e-06	0.00013	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NOS3—coronary artery disease	8.03e-06	0.000129	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCL5—coronary artery disease	8.02e-06	0.000129	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR3—coronary artery disease	7.96e-06	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR2A—coronary artery disease	7.96e-06	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PRKCD—coronary artery disease	7.95e-06	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—C3—coronary artery disease	7.95e-06	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CSF2—coronary artery disease	7.9e-06	0.000127	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CRK—coronary artery disease	7.86e-06	0.000126	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—coronary artery disease	7.82e-06	0.000126	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR3—coronary artery disease	7.79e-06	0.000125	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR2A—coronary artery disease	7.78e-06	0.000125	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—C3—coronary artery disease	7.77e-06	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SH2B3—coronary artery disease	7.76e-06	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ATP2A2—coronary artery disease	7.76e-06	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VWF—coronary artery disease	7.76e-06	0.000125	CbGpPWpGaD
Dobutamine—COMT—Metabolism—POMC—coronary artery disease	7.71e-06	0.000124	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOC3—coronary artery disease	7.71e-06	0.000124	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CRK—coronary artery disease	7.69e-06	0.000124	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LDLR—coronary artery disease	7.66e-06	0.000123	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SH2B3—coronary artery disease	7.59e-06	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ATP2A2—coronary artery disease	7.59e-06	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VWF—coronary artery disease	7.59e-06	0.000122	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AGT—coronary artery disease	7.55e-06	0.000121	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOC3—coronary artery disease	7.54e-06	0.000121	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PPP2CA—coronary artery disease	7.52e-06	0.000121	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LDLR—coronary artery disease	7.5e-06	0.000121	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL3—coronary artery disease	7.49e-06	0.00012	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL2—coronary artery disease	7.49e-06	0.00012	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SDC1—coronary artery disease	7.4e-06	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—F2R—coronary artery disease	7.4e-06	0.000119	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AGT—coronary artery disease	7.39e-06	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKCD—coronary artery disease	7.38e-06	0.000119	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PPP2CA—coronary artery disease	7.36e-06	0.000118	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—coronary artery disease	7.34e-06	0.000118	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL2—coronary artery disease	7.32e-06	0.000118	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL3—coronary artery disease	7.32e-06	0.000118	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGB—coronary artery disease	7.24e-06	0.000117	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—F2R—coronary artery disease	7.24e-06	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SDC1—coronary artery disease	7.24e-06	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR2A—coronary artery disease	7.23e-06	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKCD—coronary artery disease	7.22e-06	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—C3—coronary artery disease	7.22e-06	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDNRB—coronary artery disease	7.17e-06	0.000115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGB—coronary artery disease	7.09e-06	0.000114	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR2A—coronary artery disease	7.07e-06	0.000114	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—THBS1—coronary artery disease	7.06e-06	0.000114	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—C3—coronary artery disease	7.06e-06	0.000114	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALB—coronary artery disease	7.03e-06	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDNRB—coronary artery disease	7.01e-06	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSMB5—coronary artery disease	6.99e-06	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSMA6—coronary artery disease	6.99e-06	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—F2—coronary artery disease	6.98e-06	0.000112	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—THBS1—coronary artery disease	6.91e-06	0.000111	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AGT—coronary artery disease	6.86e-06	0.00011	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSMA6—coronary artery disease	6.84e-06	0.00011	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSMB5—coronary artery disease	6.84e-06	0.00011	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CA—coronary artery disease	6.83e-06	0.00011	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—F2—coronary artery disease	6.82e-06	0.00011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDNRA—coronary artery disease	6.77e-06	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CYBA—coronary artery disease	6.74e-06	0.000108	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NOS3—coronary artery disease	6.73e-06	0.000108	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DUSP6—coronary artery disease	6.71e-06	0.000108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AGT—coronary artery disease	6.71e-06	0.000108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDNRA—coronary artery disease	6.62e-06	0.000107	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLAT—coronary artery disease	6.6e-06	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CYBA—coronary artery disease	6.59e-06	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRB1—coronary artery disease	6.59e-06	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DUSP6—coronary artery disease	6.56e-06	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLAT—coronary artery disease	6.45e-06	0.000104	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CA—coronary artery disease	6.38e-06	0.000103	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BDKRB2—coronary artery disease	6.36e-06	0.000102	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL12—coronary artery disease	6.36e-06	0.000102	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—POMC—coronary artery disease	6.36e-06	0.000102	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—F2—coronary artery disease	6.34e-06	0.000102	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6ST—coronary artery disease	6.31e-06	0.000102	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JUNB—coronary artery disease	6.25e-06	0.000101	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	6.23e-06	0.0001	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	6.23e-06	0.0001	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	6.22e-06	0.0001	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	6.22e-06	0.0001	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—F2—coronary artery disease	6.2e-06	9.97e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	6.17e-06	9.93e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—coronary artery disease	6.15e-06	9.9e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JUNB—coronary artery disease	6.11e-06	9.83e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR7—coronary artery disease	6.09e-06	9.81e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	6.09e-06	9.8e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR7—coronary artery disease	5.96e-06	9.59e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	5.81e-06	9.34e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KNG1—coronary artery disease	5.79e-06	9.32e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—POMC—coronary artery disease	5.77e-06	9.29e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	5.77e-06	9.29e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	5.76e-06	9.26e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	5.68e-06	9.14e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KNG1—coronary artery disease	5.66e-06	9.11e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	5.65e-06	9.09e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	5.65e-06	9.08e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—POMC—coronary artery disease	5.65e-06	9.08e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	5.63e-06	9.06e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	5.63e-06	9.06e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	5.62e-06	9.05e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLG—coronary artery disease	5.61e-06	9.03e-05	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—coronary artery disease	5.58e-06	8.98e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	5.52e-06	8.89e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	5.51e-06	8.86e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	5.5e-06	8.85e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLG—coronary artery disease	5.49e-06	8.83e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	5.46e-06	8.79e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	5.39e-06	8.67e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	5.39e-06	8.67e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	5.38e-06	8.65e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—S100B—coronary artery disease	5.36e-06	8.63e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	5.31e-06	8.55e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	5.27e-06	8.49e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	5.27e-06	8.48e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	5.26e-06	8.46e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KITLG—coronary artery disease	5.25e-06	8.45e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	5.25e-06	8.45e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—S100B—coronary artery disease	5.25e-06	8.44e-05	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—coronary artery disease	5.21e-06	8.38e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	5.2e-06	8.36e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KITLG—coronary artery disease	5.13e-06	8.26e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	5.13e-06	8.26e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	5.13e-06	8.25e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP3—coronary artery disease	5.13e-06	8.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	5.02e-06	8.07e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP3—coronary artery disease	5.02e-06	8.07e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOB—coronary artery disease	4.96e-06	7.98e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	4.92e-06	7.91e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	4.89e-06	7.87e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDN1—coronary artery disease	4.88e-06	7.85e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOB—coronary artery disease	4.85e-06	7.8e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL5—coronary artery disease	4.84e-06	7.79e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	4.81e-06	7.74e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	4.78e-06	7.7e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDN1—coronary artery disease	4.77e-06	7.68e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF1—coronary artery disease	4.77e-06	7.67e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CSF2—coronary artery disease	4.77e-06	7.67e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL5—coronary artery disease	4.74e-06	7.62e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LPL—coronary artery disease	4.73e-06	7.62e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	4.69e-06	7.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	4.69e-06	7.55e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CSF2—coronary artery disease	4.67e-06	7.51e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF1—coronary artery disease	4.67e-06	7.51e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LPL—coronary artery disease	4.63e-06	7.45e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	4.59e-06	7.39e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	4.59e-06	7.39e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	4.57e-06	7.36e-05	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CA—coronary artery disease	4.52e-06	7.27e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	4.47e-06	7.2e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	4.46e-06	7.18e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	4.44e-06	7.15e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	4.37e-06	7.03e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	4.36e-06	7.02e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	4.35e-06	6.99e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	4.27e-06	6.87e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	4.27e-06	6.87e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—C3—coronary artery disease	4.26e-06	6.86e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	4.18e-06	6.72e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—C3—coronary artery disease	4.17e-06	6.71e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	4.07e-06	6.54e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGT—coronary artery disease	4.05e-06	6.52e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	3.98e-06	6.4e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOE—coronary artery disease	3.97e-06	6.39e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LEP—coronary artery disease	3.97e-06	6.39e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGT—coronary artery disease	3.96e-06	6.37e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOA1—coronary artery disease	3.92e-06	6.31e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KDR—coronary artery disease	3.89e-06	6.26e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LEP—coronary artery disease	3.88e-06	6.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOE—coronary artery disease	3.88e-06	6.25e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	3.86e-06	6.21e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOA1—coronary artery disease	3.84e-06	6.17e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KDR—coronary artery disease	3.8e-06	6.12e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ESR1—coronary artery disease	3.79e-06	6.1e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CA—coronary artery disease	3.78e-06	6.09e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	3.78e-06	6.08e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—F2—coronary artery disease	3.74e-06	6.02e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FN1—coronary artery disease	3.74e-06	6.02e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	3.73e-06	6e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ESR1—coronary artery disease	3.71e-06	5.96e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	3.7e-06	5.95e-05	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—coronary artery disease	3.69e-06	5.94e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—F2—coronary artery disease	3.66e-06	5.89e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FN1—coronary artery disease	3.66e-06	5.89e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	3.65e-06	5.87e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	3.62e-06	5.82e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KIT—coronary artery disease	3.58e-06	5.76e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KIT—coronary artery disease	3.5e-06	5.64e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	3.44e-06	5.53e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—POMC—coronary artery disease	3.41e-06	5.49e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CREB1—coronary artery disease	3.41e-06	5.49e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	3.36e-06	5.41e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL2—coronary artery disease	3.34e-06	5.37e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—POMC—coronary artery disease	3.33e-06	5.37e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CREB1—coronary artery disease	3.33e-06	5.37e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6R—coronary artery disease	3.33e-06	5.35e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1—coronary artery disease	3.28e-06	5.28e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	3.26e-06	5.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL2—coronary artery disease	3.26e-06	5.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6R—coronary artery disease	3.25e-06	5.23e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1—coronary artery disease	3.21e-06	5.16e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	3.19e-06	5.14e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.12e-06	5.02e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	3.11e-06	5.01e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—coronary artery disease	3.09e-06	4.97e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	3.05e-06	4.91e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	3.05e-06	4.9e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF2—coronary artery disease	3.01e-06	4.85e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOS3—coronary artery disease	2.97e-06	4.78e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF2—coronary artery disease	2.95e-06	4.74e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOS3—coronary artery disease	2.91e-06	4.68e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JAK2—coronary artery disease	2.89e-06	4.65e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	2.83e-06	4.56e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JAK2—coronary artery disease	2.83e-06	4.55e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	2.77e-06	4.46e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	2.64e-06	4.24e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	2.58e-06	4.15e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	2.55e-06	4.1e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—coronary artery disease	2.52e-06	4.06e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—coronary artery disease	2.51e-06	4.03e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	2.49e-06	4.01e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—coronary artery disease	2.47e-06	3.97e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCND1—coronary artery disease	2.46e-06	3.95e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—coronary artery disease	2.45e-06	3.95e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCND1—coronary artery disease	2.4e-06	3.87e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—coronary artery disease	2.39e-06	3.84e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—coronary artery disease	2.33e-06	3.75e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	2.31e-06	3.72e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	2.26e-06	3.64e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	2.14e-06	3.45e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	2.1e-06	3.37e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.97e-06	3.16e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.93e-06	3.1e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.92e-06	3.09e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.89e-06	3.03e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.67e-06	2.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.64e-06	2.63e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—coronary artery disease	1.48e-06	2.38e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—coronary artery disease	1.45e-06	2.33e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—coronary artery disease	1.37e-06	2.2e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—coronary artery disease	1.34e-06	2.15e-05	CbGpPWpGaD
